NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/12/2026
Back to search
Official data from USPTO
BIONTECH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BIONTECH
ST13
US500000087523267Class
1, 5, 16, 31, 42, 44
Filing
87523267
Registration
5712036
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
50
Latest update
03/31/2026
Trademark type
Word
Nice classes
1, 5, 16, 31, 42, 44
Filing date
07/11/2017
Registration date
04/02/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/12/2026
Last transaction
03/31/2026
Responsible office
United States Patent and Trademark Office
Status code
705
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
94
Owner location
MAINZ, DE
Examiner
WOOD, CAROLINE
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
B. S. (pessoa física)
BioNTech AG
Representatives
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.
Technical classification
Nice Classes
Class 1Class 5Class 16Class 31Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Active chemical ingredients for use in manufacture of anti-cancer drugs and vaccines ; Adjuvants for use in manufacture of vaccines; Protein arrays and nucleotide arrays for scientific and medical laboratory use; Nucleic acidsproteins and peptides for laboratory use; Diagnostic preparations for scientific or research use other than for medical purposes; Diagnostic preparations for clinical or medical laboratory use
Class 5
Pharmaceutical products for the prevention and treatment of cancerinfectious diseasesimmunological diseasesexcept vitamin preparationsmineral food supplementsprobioticsomega 3 preparationsdietetic substances and food supplements for medical and non-medical purposes; Vaccines; Adjuvants for medical purposes except vitamin preparationsmineral food supplementsprobioticsomega 3 preparationsdietetic substances and food supplements for medical and non-medical purposes; Chemical reagents used for medical or veterinary purposes; Biochemical reagents used for medical or veterinary purposes for the treatment of cancertreatment of immunological diseasestreatment of infectious diseases; Macromoleculesnucleic acid sequences and proteinsused for medical and veterinary purposes; cell based immune therapeutics for treatment of cancertreatment of immunological diseasestreatment of infectious diseases
Class 16
Pharmaceutical information leaflets; Printed pamphletsbrochuresmanualsbooksbookletsleafletsflyersinformational sheets and newsletters for providing medicalpharmaceutical and scientific research information
Class 31
Transgenic live animals and live plants for research and for the production of pharmaceuticalveterinary and biochemical goods
Class 42
Medical and scientific research in the field of treatment of immunological diseasescancer treatmenttreatment of infectious diseases ; Providing medical and scientific research informationconsultancyadvisory servicesall in the fields of treatment of immunological diseasescancer treatmenttreatment of infectious diseases; Compiling data for medical and scientific researchclinical trialsdrug admission
Class 44
Medical servicesproviding therapies for treating cancerinfectious diseases and immunological diseases; Veterinary servicesproviding therapies for treating cancerinfectious diseasesimmunological diseases; Medical and pharmaceutical consultation; Medical diagnostic testingmonitoring and reporting services ; Genetic testing for medical purposes
Publications
History of USPTO decisions and trademark events.
50 publications found
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/12/2026
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
03/11/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/27/2026
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
02/27/2026
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
02/27/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/27/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/27/2026
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
09/15/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/12/2025
E815
TEAS SECTION 8 & 15 RECEIVED
05/01/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/24/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
02/24/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/24/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/24/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/24/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/24/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/02/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/29/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/16/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/16/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
04/02/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/15/2019
PUBO
PUBLISHED FOR OPPOSITION
01/15/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/26/2018
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
11/27/2018
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
11/14/2018
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
11/09/2018
OTHE
CASE RETURNED TO EXAMINATION
10/29/2018
IUCN
NOTICE OF ALLOWANCE CANCELLED
10/29/2018
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
10/22/2018
APET
ASSIGNED TO PETITION STAFF
10/15/2018
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
09/27/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/24/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/29/2018
PUBO
PUBLISHED FOR OPPOSITION
05/29/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/09/2018
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
04/20/2018
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
04/13/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/08/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
03/19/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/19/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
03/19/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/19/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/13/2017
GNRT
NON-FINAL ACTION E-MAILED
10/13/2017
CNRT
NON-FINAL ACTION WRITTEN
10/13/2017
DOCK
ASSIGNED TO EXAMINER
10/08/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/17/2017
NWAP
NEW APPLICATION ENTERED
07/14/2017
Continuous trademark protection
Get notified about every new filing that threatens BIONTECH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.